Names, Facts, Figures about Bayer Global
Bayer is a Life Science company with a more than 150-year history and core competencies in the areas of health care and agriculture. With our innovative products, we are contributing to finding solutions to some of the major challenges of our time.
A growing and aging world population requires an adequate supply of food and improved medical care.
With our innovative products, we are contributing to finding solutions to some of the major challenges of our time. With life expectancy continuing to rise, we improve quality of life for a growing population by focusing our research and development activities on preventing, alleviating and treating diseases. We are also making an important contribution to providing a reliable supply of high-quality food, feed and plant-based raw materials.
Our goal is to create value for our customers, stockholders and employees, while also strengthening the company’s earning power. We are committed to operating sustainably and addressing our social and ethical responsibilities. Employees with a passion for innovation enjoy excellent development opportunities at Bayer. All this goes to make up our purpose:
The Bayer Group is managed as a life science company with three divisions – Pharmaceuticals, Consumer Health and Crop Science – and the Animal Health business unit, which are also our reporting segments. The corporate functions, Business Services and the service company Currenta support the operational business. In 2017, the Bayer Group comprised 237 consolidated companies in 79 countries throughout the world. As described in further detail below, Bayer’s interest in Covestro AG stood at 24.6% as at the end of the reporting period. Covestro is no longer a reportable segment and has been accounted for using the equity method as of the beginning of the fourth quarter of 2017.
Structure of the Bayer Group
Business Operations Are the Responsibility of the Divisions
The Pharmaceuticals Division focuses on prescription products, especially for cardiology and women’s healthcare, and on specialty therapeutics in the areas of oncology, hematology and ophthalmology. The division also comprises the radiology business, which markets diagnostic imaging equipment together with the necessary contrast agents.
The Consumer Health Division markets mainly nonprescription (OTC = over-the-counter) products in the dermatology, nutritional supplement, analgesic, digestive health, cold, allergy, sinus and flu, foot care and sun protection categories.
The Crop Science Division* is a world-leading agriculture enterprise with businesses in seeds, crop protection and nonagricultural pest control. The Crop Protection / Seeds operating unit markets a broad portfolio of high-value seeds and innovative pest management solutions, while at the same time providing extensive customer service for sustainable agriculture. The Environmental Science operating unit provides products and services for professional nonagricultural applications, such as vector and pest control and forestry.
* Until the divestments to BASF due to regulatory demands are completed, Monsanto will operate independently from Bayer.
The Animal Health business unit ranks among the leading international innovators in its field. It develops and markets products and solutions for the prevention and treatment of diseases in companion and farm animals.
Central Service Functions
The corporate functions and Business Servicesoperate as Group-wide competence centers in which business support services are bundled.
Currenta is the service company responsible for managing and operating the Chempark sites in Leverkusen, Dormagen and Krefeld-Uerdingen.
Dual governance system with the following governance bodies:
seven members, Chairman: Werner Baumann
20 members, Chairman: Werner Wenning
With our products, we are contributing to finding solutions to some of the major challenges of our time. The growing and increasingly aging world population requires improved medical care and an adequate supply of food. Bayer is improving people’s quality of life by preventing, alleviating and curing diseases. And we are helping to provide a reliable supply of high-quality food, feed and plant-based raw materials.
Bayer’s extensive product portfolio contains numerous globally renowned brands.
Best-selling Bayer products are:
- in the Pharmaceuticals field: Xarelto™, Eylea™, Xofigo™, Stivarga™, Adempas™, Mirena™-Produktfamilie, Kogenate™, Nexavar™, Betaferon™ / Betaseron™, Adalat™, YAZ™ / Yasmin™ / Yasminelle™, Aspirin™ Cardio, Glucobay™, Gadavist™ / Gadovist™ and Avalox™ / Avelox™
- in the Consumer Health field: Claritin™, Aspirin™, Bepanthen™ / Bepanthol™ Aleve™, Canesten™, Alka-Seltzer™-Produktfamilie, One A Day™, Dr. Scholl's™, Coppertone™ and Elevit™
- the key brands in the agriculture field are: Confidor™ / Gaucho™, the Nativo™ product family and the Prosaro™ product family
- in the Animal Health field: the Advantage™ product family, Seresto™, the Drontal™ product family and Baytril™
The Bayer Group comprises 241 consolidated companies** in 79 countries throughout the world. Global headquarters are in Leverkusen, Germany.
** fully consolidated subsidiaries (as of October. 27, 2017)
On December 31, 2017, Bayer employed 99,820 (2016: 99,592) people worldwide. In Germany we had 31,620 (2016: 30,603) employees, which was 31.7% of the total Group workforce (2016: 30.7%).
Employees by Region and Gender in 2017
|€ million||€ million||%|
|EBIT before special items2||6.826||7.130||4,5|
|EBITDA before special items2||9.318||9.288||-0,3|
|EBITDA margin before special items4||26,7%||26,5%|
|Income before income taxes||4.773||4.577||-4,1|
|Earnings per share (€)5||5,44||8,41||54,6|
|Core earnings per share (€)6||6,67||6,74||1,0|
|Net financial debt||11.778||3.595||-69,5|
|Capital expenditures as per segment table||2.627||2.418||-8,0|
|Research and development expenses||4.405||4.504||2,2|
|Dividend per Bayer AG share (€)||2,70||2,80||3,7|